DR. THROWERS PBC NO. 1

Manufacturer
DR. THROWER'S SKINCARE, INC.
Effective date
2015-05-22
Label type
HUMAN PRESCRIPTION DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 20:20:49

Label at a glance#

ProductDR. THROWERS PBC NO. 1
Active ingredientHYDROQUINONE, TRETINOIN, BETAMETHASONE DIPROPIONATE
Label structure5 sections

Indications and uses

EXTREME SKIN DISCOLORATION AND DARK SPOTS.

Dosage and administration

APPLY IN A VERY THIN LAYER IN THE DARK AREA ONLY. FOR DARK SPOTS APPLY TO THE CENTER OF DARK SPOTS. FREQUENCY OF APPLICATION: DETERMINED BY DR. THROWER.

Label contents#

Full prescribing information#

DIRECTIONS:

DOSAGE & ADMINISTRATION SECTION

APPLY IN A VERY THIN LAYER IN THE DARK AREA ONLY. FOR DARK SPOTS APPLY TO THE CENTER OF DARK SPOTS.

FREQUENCY OF APPLICATION: DETERMINED BY DR. THROWER.

USES:

INDICATIONS & USAGE SECTION

EXTREME SKIN DISCOLORATION AND DARK SPOTS.

INGREDIENTS:

INACTIVE INGREDIENT SECTION

Aqua, Ceteraryl Alcohol, Sodium Cetearyl Sulfate, Caprylic/Capric Triglyceride,Cyclopentasiloxane, Cyclohexasiloxane, Propylene Glycol, Butylene Glycol , Hydrogenated Lecithin,Sodium Oleate , Oligopeptide-68, Propanediol, Boerhavia Diffusa Root Extract ,Alcohol Denatured, Decyl Oleate, Hydrogenated Elaesis Guineensis (Palm Kernal) Oil, Hydrogenated Glycine Soja (Soybean) Oil, Hydrogenated Gossypium Herbaceum (Cotton) Seed Oil, Lecithin, Diazolidinyl Urea , Methylparaben, Propylparaben,Sodium Metabisulfite, Tocopheryl Acetate, Disodium EDTA, Sodium Hyaluronate, , Citric Acid , Aloe Barbadensis (Aloe) Leaf Juice

WARNINGS

WARNINGS SECTION

STOP USE IF SKIN BECOMES IRRITATED (PINK, RED DARKER, OR EXCESSIVE PEELING). FOR EXTERNAL USE ONLY. KEEP OUT OF REACH OF CHILDREN. FEDERAL LAW PROHIBITS THE TRANSFER OF THIS DRUG TO ANY OTHER PERSON OTHER THAN FOR WHOM IT IS PRESCRIBED.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

PBC-1 LabelPBC-1 Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
1651571betamethasone 0.5 % / hydroquinone 12 % / tretinoin 0.1 % Topical CreamPSN2
1651571betamethasone 5 MG/ML / hydroquinone 120 MG/ML / tretinoin 1 MG/ML Topical CreamSCD2
1651571betamethasone (as betamethasone dipropionate) 0.5 % / hydroquinone 12 % / tretinoin 0.1 % Topical CreamSY2
1651571betamethasone 0.5 % / hydroquinone 12 % / tretinoin 0.1 % Topical CreamSY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
BETAMETHASONE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
HYDROQUINONE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813
TRETINOIN Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
b80ad7bc-1b6f-7ef4-1ed0-86cd9f459d60Product name620251124
1426d8f8-b7d5-4053-8554-613df00c0d86Product name220250616
0e7b8bf1-c46c-4de6-b26a-0c50e34364ecProduct name220250521
dde7b902-54a1-627e-12f1-9e6d244ab88cProduct name420250317
69b49899-11cf-4f7e-bd0a-7dc93b27311bProduct name320250130
bbdc14c7-d940-43b5-a2f7-36c425991f3cProduct name120240320
0a2fcc35-464b-9ec2-a622-753662cdd48cProduct name320240216
6f762601-17ef-4321-8f47-77783d3c4d8bProduct name320231116
e3af9708-3004-7392-4046-5311eaa8bab5Product name320221128
1dbefad7-ab34-69c3-e51a-e7148aa38f70Product name520220921
13e7e7e3-e885-4c79-af6d-dad1aedbb06eProduct name120220128
7fea2046-07a9-4bb6-9409-828ac6f1f6dfProduct name120210201
f059f1a2-0e64-4839-9a7f-42687c91a44bProduct name120201007
503b047e-e62d-4745-9011-522b13bc701bProduct name120181206
7d41caa2-0b5d-9b03-ab8d-84271de26ef4Product name220170314
4ea9e4b5-b452-48ad-9b25-b9a4d403405dProduct name120160310
f31c883b-7ebf-1c60-f3b6-4ba41e8ff7a6Product name220151106
50ca9ff5-82dd-9971-4f2c-5845a76a8572Product name220150818
0a8118e4-08c6-b395-9ddc-d3e425e0493aProduct name120140508
233bcb0a-cf40-b0a1-b346-c83ac2f43579Product name120140508
4f07db9b-3707-3e2c-05b5-d7852ba808c4Product name120140508
85490a6b-2306-6bf2-c51b-eb63537dc2daProduct name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
69299-301-212020-01-31C16284748780-19d75b9d0-716b-f424-e053-dadaa90a57cef89298f4-ebf9-4568-825d-91b59146f2ee

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
69299-301-21DR. THROWERS PBC NO. 128 g in 1 JARCREAM282

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
69299-301DR. THROWERS PBC NO. 1 (HYDROQUINONE, TRETINOIN, BETAMETHASONE DIPROPIONATE) CREAM [DR. THROWER'S SKINCARE, INC.]2Legacy NDC, 1 package rows20150523_f89298f4-ebf9-4568-825d-91b59146f2ee.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
BETAMETHASONE DIPROPIONATEACTIVE INGREDIENT826Y60901U2
HYDROQUINONEACTIVE INGREDIENTXV74C1N1AE2
TRETINOINACTIVE INGREDIENT5688UTC01R2
BETAMETHASONEACTIVE MOIETY9842X06Q6M2
HYDROQUINONEACTIVE MOIETYXV74C1N1AE2
TRETINOINACTIVE MOIETY5688UTC01R2
.ALPHA.-TOCOPHEROL ACETATEINACTIVE INGREDIENT9E8X80D2L02
ALCOHOLINACTIVE INGREDIENT3K9958V90M2
ALOE VERA LEAFINACTIVE INGREDIENTZY81Z83H0X2
AMINO ACIDSINACTIVE INGREDIENT0O72R8RF8A2
ANHYDROUS CITRIC ACIDINACTIVE INGREDIENTXF417D3PSL2
BOERHAVIA DIFFUSA ROOTINACTIVE INGREDIENTKR0SR09KYL2
BUTYLENE GLYCOLINACTIVE INGREDIENT3XUS85K0RA2
CETOSTEARYL ALCOHOLINACTIVE INGREDIENT2DMT128M1S2
CYCLOMETHICONE 5INACTIVE INGREDIENT0THT5PCI0R2
CYCLOMETHICONE 6INACTIVE INGREDIENTXHK3U310BA2
DECYL OLEATEINACTIVE INGREDIENTZGR06DO97T2
DIAZOLIDINYL UREAINACTIVE INGREDIENTH5RIZ3MPW42
EDETATE DISODIUMINACTIVE INGREDIENT7FLD91C86K2
HYALURONATE SODIUMINACTIVE INGREDIENTYSE9PPT4TH2
HYDROGENATED COTTONSEED OILINACTIVE INGREDIENTZ82Y2C65EA2
HYDROGENATED PALM KERNEL OILINACTIVE INGREDIENTFM8D1RE2VP2
HYDROGENATED SOYBEAN LECITHININACTIVE INGREDIENTH1109Z9J4N2
HYDROGENATED SOYBEAN OILINACTIVE INGREDIENTA2M91M918C2
LECITHIN, SOYBEANINACTIVE INGREDIENT1DI56QDM622
MEDIUM-CHAIN TRIGLYCERIDESINACTIVE INGREDIENTC9H2L21V7U2
METHYLPARABENINACTIVE INGREDIENTA2I8C7HI9T2
PROPANEDIOLINACTIVE INGREDIENT5965N8W85T2
PROPYLENE GLYCOLINACTIVE INGREDIENT6DC9Q167V32
PROPYLPARABENINACTIVE INGREDIENTZ8IX2SC1OH2
SODIUM CETOSTEARYL SULFATEINACTIVE INGREDIENT7ZBS06BH4B2
SODIUM METABISULFITEINACTIVE INGREDIENT4VON5FNS3C2
SODIUM OLEATEINACTIVE INGREDIENT399SL044HN2
WATERINACTIVE INGREDIENT059QF0KO0R2

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 34 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
69299-30169299-301-21

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 31 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 9 · 535 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
ALCOHOLALCOHOL3K9958V90MCAPSULE / ORAL882 mgExact identifier — unii candidate
59 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TOINTMENT / TOPICAL29 mgExact identifier — unii candidate
79 equally ranked IID candidates
CETOSTEARYL ALCOHOLCETOSTEARYL ALCOHOL2DMT128M1STABLET, EXTENDED RELEASE / ORAL800 mgExact identifier — unii candidate
9 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSOLUTION/ DROPS / OPHTHALMIC0.13 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3GEL / TRANSDERMAL500 mgExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM METABISULFITESODIUM METABISULFITE4VON5FNS3CSOLUTION / ORAL640 mgExact identifier — unii candidate
43 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLLIQUID / INTRAVENOUS18 mgExact identifier — unii candidate
61 equally ranked IID candidates
HYALURONATE SODIUMHYALURONATE SODIUMYSE9PPT4THINJECTION, SUSPENSION / INTRA-ARTICULAR23 mgExact identifier — unii candidate
5 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHENEMA / RECTAL0.02 %w/wExact identifier — unii candidate
68 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLTABLET, ORALLY DISINTEGRATING / ORAL46 mgExact identifier — unii candidate
61 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHCREAM / VAGINAL3 mgExact identifier — unii candidate
68 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TTABLET, COATED / ORAL0.8 mgExact identifier — unii candidate
79 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSPRAY / NASAL5 mgExact identifier — unii candidate
61 equally ranked IID candidates
SODIUM METABISULFITESODIUM METABISULFITE4VON5FNS3CINJECTION, SOLUTION, CONCENTRATE / INTRAOCULAR0.15 %w/vExact identifier — unii candidate
43 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION / INTRABURSAL0.01 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CREAM / VAGINAL1225 mgExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM METABISULFITESODIUM METABISULFITE4VON5FNS3CINJECTION, EMULSION / INTRAVENOUS0.03 %w/vExact identifier — unii candidate
43 equally ranked IID candidates
CYCLOMETHICONE 5CYCLOMETHICONE 50THT5PCI0RAEROSOL / TOPICAL2.5 %w/wExact identifier — unii candidate
3 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLCONCENTRATE / ORAL84 mgExact identifier — unii candidate
61 equally ranked IID candidates
SODIUM CETOSTEARYL SULFATESODIUM CETOSTEARYL SULFATE7ZBS06BH4BCREAM / TOPICAL1 %w/wExact identifier — unii candidate
SODIUM METABISULFITESODIUM METABISULFITE4VON5FNS3CINJECTION, SOLUTION, CONCENTRATE / INTRAVENOUS0.15 %w/vExact identifier — unii candidate
43 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCAPSULE, EXTENDED RELEASE / ORAL8 mgExact identifier — unii candidate
59 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TENEMA / RECTAL0.18 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
HYDROGENATED SOYBEAN LECITHINHYDROGENATED SOYBEAN LECITHINH1109Z9J4NTABLET / ORAL0.21 mgExact identifier — unii candidate
4 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3CAPSULE, DELAYED RELEASE / ORAL1.7 mgExact identifier — unii candidate
81 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSOLUTION / IRRIGATION2 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION, EMULSION / INTRAVENOUS520 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION / INTRAVENOUS92 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHSUSPENSION / SUBCUTANEOUS0.02 %w/vExact identifier — unii candidate
68 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSUSPENSION / ORAL681 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SOLUTION / RESPIRATORY (INHALATION)25 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
HYDROGENATED SOYBEAN OILHYDROGENATED SOYBEAN OILA2M91M918CTABLET, EXTENDED RELEASE / ORAL96 mgExact identifier — unii candidate
4 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLINJECTION / INTRAVENOUS1152 mgExact identifier — unii candidate
61 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSOLUTION / AURICULAR (OTIC)0.1 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION / INFILTRATION80 mgExact identifier — unii candidate
79 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION, SOLUTION / SUBCUTANEOUS1.4 %w/vExact identifier — unii candidate
81 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3AEROSOL, FOAM / RECTAL1214 mgExact identifier — unii candidate
81 equally ranked IID candidates
SODIUM METABISULFITESODIUM METABISULFITE4VON5FNS3CINJECTION / PERIDURALNAExact identifier — unii candidate
43 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLINJECTION, SOLUTION / INTRAVENOUS772 mgExact identifier — unii candidate
61 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHINJECTION, SOLUTION / INTRAVENOUS5 mgExact identifier — unii candidate
68 equally ranked IID candidates
HYDROGENATED SOYBEAN OILHYDROGENATED SOYBEAN OILA2M91M918CTABLET / ORAL13.5 mgExact identifier — unii candidate
4 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KLOTION / TOPICAL22 mgExact identifier — unii candidate
77 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, METERED / RESPIRATORY (INHALATION)26664 mgExact identifier — unii candidate
59 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHCREAM, AUGMENTED / TOPICAL2 mgExact identifier — unii candidate
68 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3SWAB / TOPICAL34.6 %w/wExact identifier — unii candidate
81 equally ranked IID candidates
CETOSTEARYL ALCOHOLCETOSTEARYL ALCOHOL2DMT128M1SCREAM / TOPICAL1428 mgExact identifier — unii candidate
9 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KSOLUTION / RECTAL97 mgExact identifier — unii candidate
77 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3INJECTION, SOLUTION / INTRAMUSCULAR4000 mgExact identifier — unii candidate
81 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TINJECTION, SUSPENSION / SUBCUTANEOUS0.16 %w/vExact identifier — unii candidate
79 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLCONCENTRATE / INTRAVENOUSADJ PHExact identifier — unii candidate
61 equally ranked IID candidates
PROPYLPARABENPROPYLPARABENZ8IX2SC1OHTABLET / ORAL0.2 mgExact identifier — unii candidate
68 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION, SOLUTION / INTRAVENOUS7 mgExact identifier — unii candidate
77 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KTABLET, COATED / ORAL0.21 mgExact identifier — unii candidate
77 equally ranked IID candidates
PROPYLENE GLYCOLPROPYLENE GLYCOL6DC9Q167V3OINTMENT / DENTALNAExact identifier — unii candidate
81 equally ranked IID candidates
ANHYDROUS CITRIC ACIDANHYDROUS CITRIC ACIDXF417D3PSLSUSPENSION / RESPIRATORY (INHALATION)1 mgExact identifier — unii candidate
61 equally ranked IID candidates
SODIUM METABISULFITESODIUM METABISULFITE4VON5FNS3CINJECTION / INTRABURSAL0.2 %w/vExact identifier — unii candidate
43 equally ranked IID candidates
EDETATE DISODIUMEDETATE DISODIUM7FLD91C86KINJECTION / INTRALESIONAL0.05 %w/vExact identifier — unii candidate
77 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLIQUID / ORAL3563 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION / SUBCUTANEOUS149 mgExact identifier — unii candidate
59 equally ranked IID candidates
METHYLPARABENMETHYLPARABENA2I8C7HI9TSHAMPOO, SUSPENSION / TOPICAL0.15 %w/wExact identifier — unii candidate
79 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
615c0835-e631-4e35-8d48-e3bcddf3ef0ef89298f4-ebf9-4568-825d-91b59146f2ee2015-05-22WarningsExact identifier
spl id: 615c0835-e631-4e35-8d48-e3bcddf3ef0e
spl set id: f89298f4-ebf9-4568-825d-91b59146f2ee

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.